Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Photocure ASA : UPDATE ON MEDICARE REIMBURSEMENT FOR BLUE LIGHT CYSTOSCOPY WITH CYSVIEW®

Oslo, Norway, July 17, 2017: Photocure ASA (OSE: PHO), announced today that the United States Centers for Medicare & Medicaid Services (CMS) has released the Proposed Rule outlining its 2018 plan to reimburse hospital outpatient departments using Blue Light Cystoscopy (BLC[TM]) with Cysview[®]. To ensure appropriate reimbursement for BLCTM with Cysview, CMS has proposed to create a new set of codes specific to Blue Light Cystoscopy allowing for improved reimbursement for those procedures. The CMS draft rule for Medicare patients can be accessed at: http://bit.ly/CMS-DRAFT-Rule "We are

Outotec to deliver shutdown services to a copper smelter in South America

OUTOTEC OYJ   PRESS RELEASE, JULY 17, 2017 AT 10.00 AM Outotec to deliver shutdown services to a copper smelter in South America Outotec has been awarded a contract for shutdown services to a copper smelter in South America. The approximately EUR 12 million order has been booked in Outotec's 2017 second quarter order intake. Outotec's scope of work includes the demolition and reconstruction of a smelting furnace originally designed and delivered by Outotec. The service will be delivered during the third quarter of 2017. "This order demonstrates our commitment to delivering life-

Presentation of Probi’s Q2 report 2017

Probi’s report for the second quarter 2017 will be published on Wednesday, 19 July at 8.00 a.m. CET In conjunction with this, analysts, investors and media are invited to an audiocast telephone conference on the same day at 10.00 a.m., where CEO Peter Nählstedt and CFO Jörn Andreas will present and comment on the report. The presentation and presentation material can be obtained via www.probi.se or http://www.financialhearings.com/event/10013  The presentation can also be followed via a telephone conference on the following telephone number:Sweden: +46 8 56 64 26 91UK: +44 20 30

Leading expert on pancreatic cancer, Professor Stephen Pereira at University College London, joins Immunovia’s Scientific Advisory Board

LUND, Sweden ― Immunovia announced today that Professor Stephen Pereira, one of the globally leading experts in the diagnosis of early symptoms of pancreatic cancer and a multidisciplinary diagnostic center champion has been appointed to the company’s Scientific Advisory Board. Currently, Pereira is Professor of Hepatology & Gastroenterology at UCL, University College London, and an honorary consultant in pancreaticobiliary medicine at UCL Hospitals and The Royal Free Hospital.Professor Pereira has been involved during the last two years in the set-up of multidisciplinary diagnostic centres

NOTE’s Interim Report January–June 2017

Financial performance April–June• Sales increased by 9% to SEK 308.4 (282.4) million. Excluding divestments, sales increased by 12%.• Operating profit rose to SEK 20.3 (15.4) million.• Operating margin expanded by 1.1 percentage points to 6.6% (5.5%).• Profit after financial items increased to SEK 19.3 (13.6) million.• Profit after tax rose to SEK 11.6 (11.0) million, corresponding to SEK 0.40 (0.38) per share, of which SEK -0.14 (-) consisted of write-down of foreign deferred taxes.• Cash flow after investments amounted to SEK 1.3 (4.1) million, or SEK 0.05 (0.14) per share.

ExpreS2ion enters multi-product agreement with US-based Integrated BioTherapeutics for expansion of their commercial reagents portfolio

Hørsholm, Denmark, July 17, 2017 – Today, ExpreS2ion Biotech Holding AB announces that the fully owned subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) has entered a Master Services Agreement and a Research & Commercial License Agreement with the US based Integrated BioTherapeutics, Inc. (“IBT”). The agreements enable standardised activation of a range of services and products from ExpreS2ion. This primarily targets the development and manufacturing of proteins based on the ExpreS2 platform, as well as granting IBT commercial rights to promote, sell and distribute such protein

Handelsbanken’s interim report for January-June 2017 will be presented on July 18

Handelsbanken will present its results for January­‑June 2017 in Stockholm on July 18, 2017, at 9:00 a.m. CET, at a meeting with the media and analysts. The interim report for January‑June 2017 will be published at 7:00 a.m. CET, on July 18, 2017. A telephone conference will be held at 10:30 a.m. CET (4:30 a.m. EST), when Rolf Marquardt, CFO, will present and comment on the results. There will also be time for questions from the participants. UK number: +44 203–364 5374Swedish number: +46 8–505 564 74US number: +1 855–753 2230 Instructions1.     Dial +xx xxx xx 10

Mycronic receives order for a Prexision-MMS system and an upgrade

Täby, 17 July, 2017 - Mycronic AB (publ), has received order for a Prexision-MMS for quality assurance of advanced photomasks from a customer in Asia. The system is scheduled to be delivered in the end of 2018. At the same time, the customer has ordered an upgrade of a previously delivered mask writer Prexision-8. This system will be upgraded to a full scale Generation 10 (G10) photomask production unit.The total order value, including the Prexision-MMS and the Prexision system upgrade, is in the span USD 18-22 million.  Mycronic offers mask writers for the manufacturing of photomasks

Sales development in June 2017

The H&M group’s sales including VAT increased by 7 percent in local currencies in June 2017 compared to the same month the previous year. Converted into SEK sales increased by 10 percent. The total number of stores in the group amounted to 4,517 on 30 June 2017 compared to 4,095 stores on30 June 2016. The H&M group has decided to arrange Capital Markets Days during which more in-depth information about the business will be given and has also decided – in consultation with its large institutional shareholders – to publish the group’s sales development per quarter instead of per month.

Interim report January - June 2017

In the second quarter, Byggmax increased net sales by 2.1% and profit (EBITDA) by 8.5%  During the second quarter 2017, Byggmax Group increased sales and strengthened margins. The Group’s selling increased 2.1% following strong comparable figures for the same period last year. EBITDA margin improved significantly to 11.8%, an increase by 0.7%-points (11.1% same period last year). In June, Byggmax Group presented a new strategy, and the implementation has started according to plan.April 1 - June 30 · Net sales amounted to SEK 1,775.8 M ( 1,738.7 ), up 2.1 percent. · Net sales for

Opus signs a 20-year vehicle inspection concession agreement in Sindh Province, Pakistan

Opus Inspection VICS Sindh (Pvt) Ltd., an Opus subsidiary, won a public tender and has signed a 20-year public service vehicle inspection concession with the Transport & Mass Transit Department of the Government of Sindh (GoS) in the Sindh Province, Pakistan.Under the Sindh vehicle inspection program, Opus Inspection will design, build and operate motor vehicle inspection and certification stations (VICS) in Sindh Province to provide an exclusive, high quality, efficient, and impartial vehicle inspection program to the public. The goal of the vehicle inspection program is to improve road

Pandox AB (publ) acquires Hilton London Heathrow Airport for MGBP 80

Pandox has entered into an agreement to acquire Hilton London Heathrow Airport. The hotel is a full-service premium hotel with 398 rooms and a strong location at London-Heathrow Terminal 4. The hotel is operated by Hilton under a revenue-based lease agreement. The purchase price amounts to MGBP 80, corresponding to approximately MSEK 865, and is financed by existing credit facilities. The acquisition is expected to be completed during the third quarter 2017 and the hotel will then be reported under the business segment Property Management. For 2017 the hotel is expected to contribute the

Interim Report January – June 2017

April – June 2017 in brief ·  Order intake increased by 1.1% to SEK 7,539 M (7,460). The order intake declined organically by 3.8%.   ·  Net sales rose by 4.5% to SEK 7,241 M (6,927). Net sales decreased organically by 0.5%.  ·  Cash flow from operations declined 51.8% to SEK 223 M (463). The cash conversion amounted to 29.1% (44.7).  ·  EBITA 1* increased 9.6% to SEK 864 M (788).  ·  Restructuring and integration costs amounted to SEK 524 M (133), of which SEK 488 M comprised a provision for improvements in Hechingen in accordance with the Consent Decree with the FDA.  ·

Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M

As previously communicated the remediation program has continued at the Getinge production sites under the Consent Decree with FDA. A replanning of the ongoing remediation program has been conducted in Hechingen, Germany, and the Group has decided to make an additional provision of SEK 488 M to make the necessary changes. The costs are primarily attributable to increased staffing and process validation. After the decided provision the Group has a total remaining provision of SEK 710 M. As previously announced a US federal judge approved the terms of a Consent Decree between Getinge’s

Sandvik divests conveyor components as the final step in exiting Mining Systems

Sandvik has signed an agreement to divest the conveyor components’ parts of the Mining Systems business, including the closely related specialist conveyor systems business in Hollola (Finland), to NEPEAN Conveyors Pty Ltd, a privately owned Australian based company. As announced on 12 July 2017, Sandvik signed an agreement to divest the project business in Mining Systems to FLSmidth. By divesting also the conveyor components’ operations the exit from Mining Systems will be fully executed.  “I am pleased that we now have completed our plan enabling us to further focus on Sandvik’s

Getinge appoints Lars Sandström as CFO and member of Getinge Executive Team

Lars Sandström has been appointed Chief Financial Officer (CFO) and member of Getinge Executive Team. He has held several senior positions within the Finance organization in Scania and most recently served as Senior Vice President, Group reporting, Tax & Control in the Volvo Group. “I am very pleased that Lars has accepted the CFO role and that he will join the Getinge team. Lars has a long and broad experience from the finance area in public listed companies with global businesses. He will bring knowledge and experience both from a head office and a market perspective that will benefit

Interim Report 1 January - 30 June 2017

"A strong start of the year"1 APRIL – 30 JUNE 2017 (3 MONTHS) · Net sales rose by 23 percent to SEK 572 million (465), of which organic growth totalled 3 percent and acquired growth totalled 17 percent. · EBITA rose by 25 percent to SEK 57 million (47), corresponding to an EBITA-margin of 10.1 percent (10.0). · Profit after tax rose by 12 percent and amounted to SEK 29 million (26). · Cash flow from operating activities amounted to SEK 37 million (-6). 1 JANUARY – 30 JUNE 2017 (6 MONTHS) · Net sales rose by 25 percent to SEK 1,148 million (918), of which organic

Orkla ASA: Mandatory notification of trade - primary insiders

According to a resolution by the general meeting of Orkla ASA ("Orkla") on 20 April 2017, shareholder-elected board members are required to use minimum 1/3 of their gross board fee to purchase shares in Orkla, until they own shares in Orkla with a value equivalent to two times their gross board fee. On this basis, the following board members have purchased shares in Orkla on 14 July 2017. Stein Erik Hagen, Chairman of the Board of Orkla, has personally bought 10,000 shares at a price of NOK 86.05 per share. Following this transaction, Hagen and related parties own 249,152,000 shares in

Overall a good first half of the year

Inwido’s President and CEO, Håkan Jeppsson, comments the first half of 2017:“Inwido’s strong sales trend continues. In the second quarter, sales rose by 14 percent and, in the first half of the year, they rose by 21 percent to slightly more than SEK 3 billion (SEK 3,038 million).”  “Order bookings rose by 10 percent in the second quarter and the order backlog was 20 percent higher than at the same time in the preceding year.”  “However, earnings for the second quarter were lower than we expected. Following 11 consecutive record quarters, operating profit ended up at SEK 193 million (

Interim report January-June 2017

This information is such that Inwido AB (publ) is obliged to publish in accordance with the EU market abuse regulation and the Swedish Securities Market Act. The information was submitted by the below contact persons for publication on 17 July 2017 at 7:45 a.m. CET.  A good first half of 2017 April – June 2017 · Net sales rose to SEK 1,673 million (1,470), representing an increase of 14 percent. Organic growth was 1 percent · EBITA amounted to SEK 192 million (202) after items affecting comparability of a negative SEK 1 million (negative 6), and the EBITA margin was 11.5 percent

Notice of Extraordinary General Meeting in Getinge AB

The shareholders of Getinge AB (publ) are hereby invited to attend the Extraordinary General Meeting (the “EGM”) to be held on Tuesday August 15, 2017 at 11.00 CEST, at Clarion Hotel Post, Drottningtorget 10 in Gothenburg, Sweden. Right to attend Shareholders who wish to attend the EGM must: – be recorded in the share register kept by Euroclear Sweden AB (the Swedish Central Securities Depository), on Wednesday 9 August 2017, and – notify the company of their intention to attend the EGM by Wednesday 9 August 2017, preferably before 4.00 p.m. CET. In order to participate in

International point of view: Kiilto in Estonia

In the 1910s, pharmacists were busy looking for hair tonic and mouthwash to sell, shoe factories were lacking paints, shoe polish, waxes and adhesives, and furniture factories were in need of varnishes and polish waxes. The name Kiilto (“gloss”) refers to the type of products the company produced in its early years. Currently, Kiilto develops and produces adhesives and related products and systems for construction, renovation and industrial use from the uppermost layers all the way down to the base. OÜ Kiilto Eesti, founded in 1999, is an importer and wholesaler of construction products and

KONE to supply elevators and escalators for a high-end mixed-use complex in Shenzhen, China

KONE Corporation, press release, July 17, 2017 KONE, a global leader in the elevator and escalator industry, has won an order to supply 31 KONE high-rise elevators to OCT Tower, a mixed-use development comprising offices and a commercial center. Standing at a height of 300 meters after completion, OCT Tower will not only become an urban visual landmark, but also a synthesis of space, structure and façade. KONE will be supplying 26 KONE MiniSpace[TM] elevators and 5 KONE Double Deck elevators with a maximum speed of up to 6m/s. Special features include KONE Destination

There are no items matching the current filter
There are no more items matching the current filter
Back to top